Palisade Bio Correlations
PALI Stock | USD 0.80 0.01 1.48% |
The correlation of Palisade Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Palisade Bio Correlation With Market
Significant diversification
The correlation between Palisade Bio and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and DJI in the same portfolio, assuming nothing else is changed.
Palisade |
Moving together with Palisade Stock
0.9 | EYEN | Eyenovia | PairCorr |
0.67 | MOLN | Molecular Partners Upward Rally | PairCorr |
0.67 | SNDL | SNDL Inc | PairCorr |
0.89 | CLDX | Celldex Therapeutics | PairCorr |
0.78 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.68 | CRVS | Corvus Pharmaceuticals Downward Rally | PairCorr |
0.66 | GKOS | Glaukos Corp | PairCorr |
0.63 | LIVN | LivaNova PLC | PairCorr |
0.86 | MODD | Modular Medical | PairCorr |
0.75 | APYX | Apyx Medical | PairCorr |
0.83 | SGHT | Sight Sciences | PairCorr |
0.83 | SRDX | SurModics | PairCorr |
0.78 | CNMD | CONMED | PairCorr |
Moving against Palisade Stock
0.87 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.87 | FNA | Paragon 28 | PairCorr |
0.71 | CMRX | Chimerix | PairCorr |
0.38 | OPT | Opthea | PairCorr |
0.92 | NVRO | Nevro Corp Sell-off Trend | PairCorr |
0.88 | LUCD | Lucid Diagnostics | PairCorr |
0.76 | INMD | InMode | PairCorr |
0.67 | LUNG | Pulmonx Corp | PairCorr |
0.55 | NYXH | Nyxoah | PairCorr |
0.44 | MASI | Masimo | PairCorr |
0.88 | BRK-A | Berkshire Hathaway | PairCorr |
0.88 | BRK-B | Berkshire Hathaway | PairCorr |
0.63 | FWEDF | Fireweed Zinc | PairCorr |
0.58 | TRGGF | Tarachi Gold Corp | PairCorr |
0.52 | TMCI | Treace Medical Concepts | PairCorr |
0.52 | TOI | Oncology Institute Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Palisade Stock performing well and Palisade Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Palisade Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ZURA | 4.83 | (0.48) | 0.00 | (0.27) | 0.00 | 9.79 | 29.06 | |||
CYTO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IMMX | 3.45 | (0.15) | 0.00 | (2.93) | 0.00 | 6.82 | 26.42 | |||
ENVB | 7.02 | (0.66) | 0.00 | (0.52) | 0.00 | 12.04 | 113.38 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
VIRI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ZVSA | 4.52 | (0.37) | 0.00 | (1.03) | 0.00 | 12.03 | 38.26 | |||
PHIO | 11.11 | 2.17 | 0.18 | 0.45 | 9.68 | 9.40 | 336.29 | |||
NBY | 3.68 | 0.31 | 0.08 | 15.09 | 4.31 | 8.57 | 26.43 |
Palisade Bio Corporate Management
Joerg Heyer | Head Medicine | Profile | |
Ryker Willie | Senior Controller | Profile | |
Sharon McBrayer | Director Operations | Profile | |
Mitchell MD | Chief Officer | Profile | |
Robert McRae | VP Devel | Profile | |
MD FAAAAI | Chief Officer | Profile |